Tuesday, July 9
FT News Briefing
00:00
Intro
This chapter explores the decline in Chinese venture capital investments in U.S. biotech, driven by increased U.S. government scrutiny. It also discusses BASF's lowered forecasts amidst economic slowdowns and Deutsche Bank's significant restructuring efforts, indicating a challenging period for financial entities.
Play episode from 00:00
Transcript
